The global Newborn Screening Program market was valued at US$ 660 million in 2023 and is anticipated to reach US$ 777.4 million by 2030, witnessing a CAGR of 2.4% during the forecast period 2024-2030.
North American market for Newborn Screening Program is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Newborn Screening Program is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Newborn Screening Program in General Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Newborn Screening Program include AB Sciex, Agilent Technologies, Bio-Rad Laboratories, Cytiva, Masimo, Medtronic, Natus Medical, PerkinElmer and Zentech Manufacturing, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Newborn Screening Program, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newborn Screening Program.
Report Scope
The Newborn Screening Program market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Newborn Screening Program market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Newborn Screening Program companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AB Sciex
Agilent Technologies
Bio-Rad Laboratories
Cytiva
Masimo
Medtronic
Natus Medical
PerkinElmer
Zentech Manufacturing
Segment by Type
Hypothyroidism
Phenylketonuria
Galactosemia
Sickle Cell Disease
Others
Segment by Application
General Hospitals
Specialty Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Newborn Screening Program companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Newborn Screening Program Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hypothyroidism
1.2.3 Phenylketonuria
1.2.4 Galactosemia
1.2.5 Sickle Cell Disease
1.2.6 Others
1.3 Market by Application
1.3.1 Global Newborn Screening Program Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 General Hospitals
1.3.3 Specialty Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Newborn Screening Program Market Perspective (2019-2030)
2.2 Newborn Screening Program Growth Trends by Region
2.2.1 Global Newborn Screening Program Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Newborn Screening Program Historic Market Size by Region (2019-2024)
2.2.3 Newborn Screening Program Forecasted Market Size by Region (2025-2030)
2.3 Newborn Screening Program Market Dynamics
2.3.1 Newborn Screening Program Industry Trends
2.3.2 Newborn Screening Program Market Drivers
2.3.3 Newborn Screening Program Market Challenges
2.3.4 Newborn Screening Program Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Newborn Screening Program Players by Revenue
3.1.1 Global Top Newborn Screening Program Players by Revenue (2019-2024)
3.1.2 Global Newborn Screening Program Revenue Market Share by Players (2019-2024)
3.2 Global Newborn Screening Program Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Newborn Screening Program Revenue
3.4 Global Newborn Screening Program Market Concentration Ratio
3.4.1 Global Newborn Screening Program Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Newborn Screening Program Revenue in 2023
3.5 Newborn Screening Program Key Players Head office and Area Served
3.6 Key Players Newborn Screening Program Product Solution and Service
3.7 Date of Enter into Newborn Screening Program Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Newborn Screening Program Breakdown Data by Type
4.1 Global Newborn Screening Program Historic Market Size by Type (2019-2024)
4.2 Global Newborn Screening Program Forecasted Market Size by Type (2025-2030)
5 Newborn Screening Program Breakdown Data by Application
5.1 Global Newborn Screening Program Historic Market Size by Application (2019-2024)
5.2 Global Newborn Screening Program Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Newborn Screening Program Market Size (2019-2030)
6.2 North America Newborn Screening Program Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Newborn Screening Program Market Size by Country (2019-2024)
6.4 North America Newborn Screening Program Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Newborn Screening Program Market Size (2019-2030)
7.2 Europe Newborn Screening Program Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Newborn Screening Program Market Size by Country (2019-2024)
7.4 Europe Newborn Screening Program Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Newborn Screening Program Market Size (2019-2030)
8.2 Asia-Pacific Newborn Screening Program Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Newborn Screening Program Market Size by Region (2019-2024)
8.4 Asia-Pacific Newborn Screening Program Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Newborn Screening Program Market Size (2019-2030)
9.2 Latin America Newborn Screening Program Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Newborn Screening Program Market Size by Country (2019-2024)
9.4 Latin America Newborn Screening Program Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Newborn Screening Program Market Size (2019-2030)
10.2 Middle East & Africa Newborn Screening Program Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Newborn Screening Program Market Size by Country (2019-2024)
10.4 Middle East & Africa Newborn Screening Program Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AB Sciex
11.1.1 AB Sciex Company Detail
11.1.2 AB Sciex Business Overview
11.1.3 AB Sciex Newborn Screening Program Introduction
11.1.4 AB Sciex Revenue in Newborn Screening Program Business (2019-2024)
11.1.5 AB Sciex Recent Development
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Detail
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Newborn Screening Program Introduction
11.2.4 Agilent Technologies Revenue in Newborn Screening Program Business (2019-2024)
11.2.5 Agilent Technologies Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Newborn Screening Program Introduction
11.3.4 Bio-Rad Laboratories Revenue in Newborn Screening Program Business (2019-2024)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Cytiva
11.4.1 Cytiva Company Detail
11.4.2 Cytiva Business Overview
11.4.3 Cytiva Newborn Screening Program Introduction
11.4.4 Cytiva Revenue in Newborn Screening Program Business (2019-2024)
11.4.5 Cytiva Recent Development
11.5 Masimo
11.5.1 Masimo Company Detail
11.5.2 Masimo Business Overview
11.5.3 Masimo Newborn Screening Program Introduction
11.5.4 Masimo Revenue in Newborn Screening Program Business (2019-2024)
11.5.5 Masimo Recent Development
11.6 Medtronic
11.6.1 Medtronic Company Detail
11.6.2 Medtronic Business Overview
11.6.3 Medtronic Newborn Screening Program Introduction
11.6.4 Medtronic Revenue in Newborn Screening Program Business (2019-2024)
11.6.5 Medtronic Recent Development
11.7 Natus Medical
11.7.1 Natus Medical Company Detail
11.7.2 Natus Medical Business Overview
11.7.3 Natus Medical Newborn Screening Program Introduction
11.7.4 Natus Medical Revenue in Newborn Screening Program Business (2019-2024)
11.7.5 Natus Medical Recent Development
11.8 PerkinElmer
11.8.1 PerkinElmer Company Detail
11.8.2 PerkinElmer Business Overview
11.8.3 PerkinElmer Newborn Screening Program Introduction
11.8.4 PerkinElmer Revenue in Newborn Screening Program Business (2019-2024)
11.8.5 PerkinElmer Recent Development
11.9 Zentech Manufacturing
11.9.1 Zentech Manufacturing Company Detail
11.9.2 Zentech Manufacturing Business Overview
11.9.3 Zentech Manufacturing Newborn Screening Program Introduction
11.9.4 Zentech Manufacturing Revenue in Newborn Screening Program Business (2019-2024)
11.9.5 Zentech Manufacturing Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
AB Sciex
Agilent Technologies
Bio-Rad Laboratories
Cytiva
Masimo
Medtronic
Natus Medical
PerkinElmer
Zentech Manufacturing
*If Applicable.